Comparative Pharmacology
Head-to-head clinical analysis: POTASSIUM ACETATE versus SODIUM ACETATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: POTASSIUM ACETATE versus SODIUM ACETATE.
POTASSIUM ACETATE vs SODIUM ACETATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Potassium acetate provides potassium ions, which are essential for maintaining intracellular ionic balance, nerve conduction, muscle contraction, and acid-base equilibrium. It acts as a potassium replenisher and can also be used to alkalinize urine by converting to bicarbonate.
Sodium acetate provides sodium ions and acetate ions. Acetate is metabolized to bicarbonate, which acts as a buffer to correct metabolic acidosis.
Intravenous, 10-20 mEq/h, maximum infusion rate 20 mEq/h, not to exceed 150 mEq/day.
Intravenous: 50-200 mL of 0.1-0.4 mEq/mL solution per dose; administer at a rate not exceeding 1 mEq/kg/hour; frequency based on serum bicarbonate and acid-base status.
None Documented
None Documented
Not applicable as potassium is not eliminated by first-order kinetics; plasma concentration reflects body stores and renal function.
2-3 minutes (rapid conversion to bicarbonate in circulation). Clinical context: Exogenous acetate (e.g., in parenteral nutrition) is quickly cleared, limiting duration of alkalinizing effect.
Primarily renal (>90%) as potassium ions; minimal biliary/fecal.
Primarily renal; acetate is rapidly metabolized to bicarbonate via the Krebs cycle, with less than 5% excreted unchanged in urine.
Category C
Category C
Electrolyte Supplement
Electrolyte Supplement